These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 15129708)

  • 21. Rhenium-188 based radiopharmaceuticals for treatment of liver tumours.
    Lambert B; Bacher K; Defreyne L
    Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):305-10. PubMed ID: 19521309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of postsurgical recurrence of hepatocellular carcinoma with rhenium 188-HDD labeled iodized oil.
    Kumar A; Srivastava DN; Bal C
    J Vasc Interv Radiol; 2006 Jan; 17(1):157-61. PubMed ID: 16415146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The anti-tumoral activity of neoadjuvant intra-arterial 131I-lipiodol treatment for hepatocellular carcinoma: a pilot study.
    Brans B; De Winter F; Defreyne L; Troisi R; Vanlangenhove P; Van Vlierberghe H; Lambert B; Praet M; de Hemptinne B; Dierckx RA
    Cancer Biother Radiopharm; 2001 Aug; 16(4):333-8. PubMed ID: 11603004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intra-arterial iodine 131-labeled lipiodol as adjuvant therapy after curative liver resection for hepatocellular carcinoma: a phase 2 clinical study.
    Partensky C; Sassolas G; Henry L; Paliard P; Maddern GJ
    Arch Surg; 2000 Nov; 135(11):1298-300. PubMed ID: 11074884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radionuclide therapy of hepatocellular carcinoma.
    Keng GH; Sundram FX
    Ann Acad Med Singap; 2003 Jul; 32(4):518-24. PubMed ID: 12968558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radionuclide therapy of hepatocellular carcinoma.
    Sundram F
    Biomed Imaging Interv J; 2006 Jul; 2(3):e40. PubMed ID: 21614248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Report of a pilot study of intra-arterial injection of I-131 lipiodol for the treatment of hepatoma.
    Lui WY; Liu RS; Chiang JH; Lo JG; Lai KH; King KL; Cheng HC; Wei YY; Chi CW; P'eng FK
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Sep; 46(3):125-33. PubMed ID: 2178041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Radiotherapy with (186)Re-lipiodol II for primary liver cancer patients].
    Shi L; Zhang Z; Zhuang D; Cheng H; Gao Y; Wu M
    Zhonghua Wai Ke Za Zhi; 2002 Nov; 40(11):814-6. PubMed ID: 12487852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival.
    Kirchhoff TD; Bleck JS; Dettmer A; Chavan A; Rosenthal H; Merkesdal S; Frericks B; Zender L; Malek NP; Greten TF; Kubicka S; Manns MP; Galanski M
    Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):259-66. PubMed ID: 17548248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transarterial internal radiation therapy with I-131 Lipiodol for multifocal hepatocellular carcinoma: immediate and long-term results.
    Kajiya Y; Kobayashi H; Nakajo M
    Cardiovasc Intervent Radiol; 1993; 16(3):150-7. PubMed ID: 8392913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma.
    Raoul JL; Guyader D; Bretagne JF; Heautot JF; Duvauferrier R; Bourguet P; Bekhechi D; Deugnier YM; Gosselin M
    Hepatology; 1997 Nov; 26(5):1156-61. PubMed ID: 9362356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intra-arterial injection of 131I-labeled Lipiodol for advanced hepatocellular carcinoma: a 7 years' experience.
    Lintia-Gaultier A; Perret C; Ansquer C; Eugène T; Kraeber-Bodéré F; Frampas E
    Nucl Med Commun; 2013 Jul; 34(7):674-81. PubMed ID: 23587835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preliminary results of the Phase 1 Lip-Re I clinical trial: biodistribution and dosimetry assessments in hepatocellular carcinoma patients treated with
    Delaunay K; Edeline J; Rolland Y; Lepareur N; Laffont S; Palard X; Bouvry C; Le Sourd S; Pracht M; Ardisson V; Noiret N; Bellissant É; Garin E
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1506-1517. PubMed ID: 30715571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Transarterial chemoembolization with high dose iodized oil for the treatment of large hepatocellular carcinoma].
    Chen M; Li J; Zhang Y
    Zhonghua Zhong Liu Za Zhi; 2001 Mar; 23(2):165-7. PubMed ID: 11783027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival after 131I-labeled lipiodol therapy for hepatocellular carcinoma. A single-center study based on a long-term follow-up.
    Ahmadzadehfar H; Habibi E; Ezziddin S; Wilhelm K; Fimmers R; Spengler U; Palmedo H; Strunk H; Schild HH; Biersack HJ; Risse J
    Nuklearmedizin; 2014; 53(2):46-53. PubMed ID: 24468919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 188rhenium-TDD-lipiodol in treatment of inoperable primary hepatocellular carcinoma--a case report.
    Sundram FX; Yu SW; Jeong JM; Somanesan S; Premaraj J; Saw MM; Tan BS
    Ann Acad Med Singap; 2001 Sep; 30(5):542-5. PubMed ID: 11603144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective radionuclide localisation in primary liver tumours (pilot study).
    Novell JR; Green AJ; Hilson AJ; Dusheiko G; Dick R; Hobbs KE
    HPB Surg; 1994; 7(3):185-99; discussion 200. PubMed ID: 8155585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective phase 2 multicenter study for the efficacy of radiation therapy following incomplete transarterial chemoembolization in unresectable hepatocellular carcinoma.
    Choi C; Koom WS; Kim TH; Yoon SM; Kim JH; Lee HS; Nam TK; Seong J
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1051-60. PubMed ID: 25303890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival.
    Lau WY; Lai EC; Leung TW; Yu SC
    Ann Surg; 2008 Jan; 247(1):43-8. PubMed ID: 18156922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of unresectable hepatocellular carcinoma with radiolabelled lipiodol.
    Kanhere HA; Leopardi LN; Fischer L; Kitchener MI; Maddern GJ
    ANZ J Surg; 2008 May; 78(5):371-6. PubMed ID: 18380736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.